Last reviewed · How we verify
cabozantinib capsules
At a glance
| Generic name | cabozantinib capsules |
|---|---|
| Also known as | XL184 |
| Sponsor | Exelixis |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- cabozantinib capsules CI brief — competitive landscape report
- cabozantinib capsules updates RSS · CI watch RSS
- Exelixis portfolio CI